ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	27 February 2023
Main ID:	NCT02431715
Date of registration:	27/04/2015
Prospective Registration:	Yes
Primary sponsor:	British Columbia Cancer Agency
Public title:	18F-FDOPA PET in Neuroendocrine Tumours
Scientific title:	[18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA) Positron Emission Tomography (PET) in Neuroendocrine Tumours
Date of first enrolment:	June 29, 2015
Target sample size:
Recruitment status:	No longer available
URL:	https://clinicaltrials.gov/show/NCT02431715
Study type:	Expanded Access
Study design:
Phase:

Countries of recruitment
Canada

Contacts

Key inclusion & exclusion criteria

Inclusion Criteria

- Patients who meet the BCCA approved clinical indications for 18F-FDOPA PET/CT scans in
neuroendocrine tumours.

- ECOG performance status 0 - 3.

- Able to provide written informed consent (or consent by guardian for subjects <19
years).

- Referred by a treating BC physician.

- Patients must be able to tolerate the physical/logistical requirements of completing a
PET scan including lying flat for up to 40 minutes and tolerating intravenous
cannulation for injection.

Exclusion Criteria

- Pregnancy.

- Patients who are medically unstable eg. acute cardiac or respiratory distress,
hypotensive

- Patients who exceed the safe weight limit of the PET/CT bed (204.5 kg) or who cannot
fit through the PET/CT bore (diameter 70 cm).

Age minimum: 1 Month
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Insulinoma

Neuroblastoma

Carcinoid Tumor

Paraganglioma

Pheochromocytoma

Thyroid Cancer, Medullary

Intervention(s)

Drug: [18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA)

Primary Outcome(s)

Secondary Outcome(s)

Secondary ID(s)

H12-01795

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.